Company intelligence / Profile preview
Temprian Therapeutics
Chicago, Illinois, USAtempriantherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Temprian Therapeutics, a Northwestern University spin-off, develops novel therapies for autoimmune skin diseases and cancer. Its lead program uses a gene therapy approach to treat vitiligo by reversing the immune attack on pigment cells. The company also has a nanoparticle-based "Supercarrier" platform targeting metastatic cutaneous and ocular melanoma. Both programs are based on decades of research from Prof. Caroline Le Poole’s lab and collaborators at Northwestern University. Clinical results have not yet been published; programs are preclinical or entering early clinical stages[1][2][4].
- Therapeutic areas
- OncologyDermatology
- Modalities
- Gene therapy (DNA plasmid)Nanoparticle-based prodrug delivery
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaboration with Northwestern University labs; no major pharma partnerships disclosed[1][4].
Beyond the preview
Go deeper on Temprian Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Temprian Therapeutics.